Open label evaluation of the novel antipsychotic compound BW234U in chronic schizophrenics
- 1 January 1985
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 5 (4), 387-393
- https://doi.org/10.1002/ddr.430050412
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Psychotropic actions of BW 234U in the treatment of inpatient schizophrenics: A dose-range studyDrug Development Research, 1983
- BW234U,(cis-9-[3–(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agentJournal of Pharmacy and Pharmacology, 1982